Three things we learned from our panelists at DeviceTalks Boston:
-𝐖𝐡𝐲 𝐰𝐞 𝐢𝐧𝐯𝐞𝐬𝐭𝐞𝐝 𝐞𝐚𝐫𝐥𝐲 𝐢𝐧 𝐭𝐡𝐞 𝐅𝐀𝐑𝐀𝐏𝐔𝐋𝐒𝐄™ 𝐏𝐮𝐥𝐬𝐞𝐝 𝐅𝐢𝐞𝐥𝐝 𝐀𝐛𝐥𝐚𝐭𝐢𝐨𝐧 𝐒𝐲𝐬𝐭𝐞𝐦 💓 “When we look at investing, there has to be an unmet need -- a problem we’re trying to solve for patients, operators, the care system and payers. That was true of FARAPULSE. 38 million people worldwide live with atrial fibrillation. So there’s a huge market need for a safe and effective solution, and also an opportunity to provide a more efficient technology and workflow.” –Nick Spadea-Anello, Global President of Electrophysiology (with Sean McNulty, VP, R&D, Electrophysiology)
-𝐎𝐧 𝐭𝐡𝐞 𝐜𝐨𝐦𝐢𝐧𝐠 𝐫𝐨𝐥𝐞 𝐨𝐟 𝐀𝐈 🤖 “The opportunity that artificial intelligence could create in healthcare is significant – but AI is not a replacement for human expertise. Rather, it’s a complement and an assistant that will speed up processes and workflows, and accelerate faster decisions.” –Sandra Nagale, Ph.D., Director of Digital Health Platforms and Products
-𝐎𝐧 𝐨𝐮𝐫 𝐬𝐮𝐬𝐭𝐚𝐢𝐧𝐚𝐛𝐢𝐥𝐢𝐭𝐲 𝐞𝐟𝐟𝐨𝐫𝐭𝐬 🌲 “I’m proud to say that last year, we achieved 82% renewable electricity in our manufacturing and key distribution sites. Our goal is to be at 100% renewable electricity by the end of 2024.” –Kathryn Graves Unger, VP of Environmental, Social and Governance
Love this❤️